Abstract 2415: Polygenic risk-tailored screening for prostate cancer: A cost-effectiveness analysis

Polygenic Risk ◽

Abstract 2415: Polygenic risk-tailored screening for prostate cancer: A cost-effectiveness analysis

10.1158/1538-7445.am2019-2415 ◽

2019 ◽

Author(s):

Thomas Callender ◽

Mark Emberton ◽

Steve Morris ◽

Ros Eeles ◽

Zsofia Kote-Jarai ◽

...

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Polygenic Risk ◽

01 / COST-EFFECTIVENESS ANALYSIS OF AN EXERCISE INTERVENTION TARGETING PHYSICAL FUNCTIONING IN LONG TERM SURVIVORS OF PROSTATE CANCER PREVIOUSLY TREATED WITH ANDROGEN DEPRIVATION THERAPY

10.26226/morressier.5afadd8af314ac000849b335 ◽

2018 ◽

Author(s):

Kim Edmunds

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Androgen Deprivation Therapy ◽

Physical Functioning ◽

Exercise Intervention ◽

Effectiveness Analysis ◽

Previously Treated ◽

Long Term Survivors

Cost-effectiveness analysis of innovative therapy for patients with newly diagnosed hormone-sensitive metastatic prostate cancer

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2021.03.022 ◽

2021 ◽

Author(s):

Rémi Pelloux-Prayer ◽

Philomène Schiele ◽

Stéphane Oudard ◽

Gwenaëlle Gravis ◽

François Kleinclauss ◽

...

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Metastatic Prostate Cancer ◽

Newly Diagnosed ◽

Innovative Therapy ◽

Effectiveness Analysis ◽

Hormone Sensitive

Cost-Effectiveness Analysis of Abiraterone and Sipuleucel-T in Metastatic Castration-Resistant Prostate Cancer

Value in Health ◽

10.1016/j.jval.2014.03.482 ◽

2014 ◽

Vol 17 (3) ◽

pp. A82-A83

Author(s):

C.L. Gong ◽

J.W. Hay

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Will the Addition of Second Generation Anti-Androgens in Addition to Standard Androgen-Deprivation Therapy and Radiotherapy be Cost-Effective in the Treatment of Node Positive Prostate Cancer: A Cost-Effectiveness Analysis

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.1471 ◽

2019 ◽

Vol 105 (1) ◽

pp. E440

Author(s):

A.A. Konski ◽

R.C. Chen ◽

L. Havrilesky ◽

O. Sartor ◽

J.A. Efstathiou

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Androgen Deprivation Therapy ◽

Second Generation ◽

Cost Effective ◽

Androgen Deprivation ◽

Node Positive ◽

Cost-effectiveness analysis of treatments for metastatic castration resistant prostate cancer

Asian Journal of Urology ◽

10.1016/j.ajur.2016.11.005 ◽

2017 ◽

Vol 4 (1) ◽

pp. 37-43 ◽

Cited By ~ 19

Author(s):

Matthew E. Pollard ◽

Alan J. Moskowitz ◽

Michael A. Diefenbach ◽

Simon J. Hall

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Risk assessment to guide prostate cancer screening decisions: a cost‐effectiveness analysis

The Medical Journal of Australia ◽

10.5694/mja12.11597c ◽

2014 ◽

Vol 200 (4) ◽

pp. 205-205

Author(s):

Andrew J Martin ◽

Sarah J Lord ◽

Hannah E Verry ◽

Martin R Stockler ◽

Jon D Emery

Keyword(s):

Prostate Cancer ◽

Risk Assessment ◽

Cost Effectiveness ◽

Cancer Screening ◽

Prostate Cancer Screening ◽

Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France

BMC Medical Imaging ◽

10.1186/s12880-020-00425-y ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Mathieu Gauthé ◽

Kevin Zarca ◽

Cyrielle Aveline ◽

Frédéric Lecouvet ◽

Sona Balogova ◽

...

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Bone Metastases ◽

Sodium Fluoride ◽

Diffusion Weighted Mri ◽

Recurrent Prostate Cancer ◽

Effectiveness Analysis ◽

Pet Ct ◽

And Diffusion

Cost-effectiveness analysis of Abiraterone Acetate versus Docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong’s perspective

Prostate Cancer and Prostatic Diseases ◽

10.1038/s41391-019-0161-2 ◽

2019 ◽

Vol 23 (1) ◽

pp. 108-115 ◽

Cited By ~ 2

Author(s):

Chi Leung Chiang ◽

Tsz Him So ◽

Tai Chung Lam ◽

Horace C. W. Choi

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Abiraterone Acetate ◽

A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate Cancer

European Urology Oncology ◽

10.1016/j.euo.2019.01.004 ◽

2019 ◽

Vol 2 (6) ◽

pp. 649-655 ◽

Cited By ~ 13

Author(s):

Niranjan J. Sathianathen ◽

Fernando Alarid-Escudero ◽

Karen M. Kuntz ◽

Nathan Lawrentschuk ◽

Damien M. Bolton ◽

...

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Systemic Therapy ◽

Effectiveness Analysis ◽

Hormone Sensitive